Acuitive’s mission is to advance the art and science of orthopedic surgery by developing material technologies in combination with unique device designs that more effectively address the clinical problems facing current "state of the art" orthopedic devices. We are committed to serve our customers by delivering safe and effective orthopedic devices through material advancements, unique designs, and cost-conscious manufacturing. We shall accomplish this while meeting customer and regulatory requirements, monitoring the effectiveness of our quality system, and periodically reviewing our objectives.
Inspired by nature, CITREGEN is a paradigm-changing synthetic biomaterial purposefully designed on a molecular level to replicate the intrinsic cellular support network. CITREGEN's main component, citrate, is historically known as a naturally occurring metabolic molecule but has recently been shown to play important roles in bone anatomy.
Acuitive Technologies Inc. was founded in 2014 by four partners with decades of experience in developing novel platform material science technologies to address current clinical problems associated with orthopedic devices. CITREGEN is the latest innovation in a history of successful technology introductions.
We address clinical needs by leveraging advanced material science chemistry and novel designs to develop products that will improve patient lives.
We maintain a commitment to quality by establishing, reviewing, communicating, and practicing the Quality Policies and Objectives throughout the organization.
Safety & Compliance
We thoroughly test products and materials to show that they meet or exceed industry standards while maintaining an effective quality management system and adhering to all applicable laws and regulations.